Purchase Order W81XWH21P0037

<p>The Defense Health Agency awarded a $1,099,986.24 definitive contract to CFD Research Corporation for flexible microfluidic process technology for biopharmaceutical purification of bacteriophages on February 1, 2023, under a total small business set-aside.</p> <p>This is an STTR Phase II award. The contract carries a firm fixed price structure and an ultimate completion date of November 30, 2025. Place of performance is Huntsville, AL.</p>

<p>The Defense Health Agency (DHA) awarded a Small Business Innovation Research (SBIR) Phase I contract worth $147,960.00 to Fosmo Med, Inc., a minority-owned, self-certified small disadvantaged business and manufacturer of goods. The contract, designated as a Total Small Business set-aside, has a completion date of December 25, 2018 and is a Definitive Contract with a Firm Fixed Price pricing type. The place of performance is San Mateo, CA 94401, USA.</p>

The Department of the Army Medical Command awarded a $166,492.05 Small Business Innovation Research (SBIR) Phase I contract to CFD Research Corporation, doing business as CFD Research, for the development of a &quot;Portable Automated Phage Isolation Technology.&quot; This firm-fixed-price contract was set aside for small businesses. CFD Research, a for-profit engineering and technology services firm, has a history of providing computational fluid dynamics research, artificial intelligence,...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to CFD Research Corporation, a for-profit organization, to perform Phase I SBIR research on a &quot;SMART BIOREACTOR FOR LARGE-SCALE HIGH TITER PHAGE PREPS&quot; project. The contract has a potential value of $299,946.26 and a completion date of August 15, 2022. This SBIR award was not set aside for a specific business...

This award is for a $1,074,903.98 Firm Fixed Price contract under the Defense Health Agency's (DHA) Small Business Innovation Research (SBIR) program. The contract was awarded to Chromologic LLC, a minority-owned small business, for the development of a Phase II project titled &quot;In-Line, Non-Invasive, Non-Destructive Cell Monitoring in Dynamically Growing Cultures&quot;. The project was solicited under DHA SBIR Topic DHA18-006, and the work is to be performed in Monrovia, California....

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price Definitive Contract to Adaptive Phage Therapeutics, Inc. to develop a rapid and scalable method for bacteriophage manufacture and purification under the Small Business Innovation Research (SBIR) Phase I program. The contract has a potential value of $296,787.00 and a completion date of August 15, 2022. This contract is not set...

The Defense Health Agency (DHA) awarded a $250K Small Business Innovation Research (SBIR) Phase I contract to CFD Research Corporation for development of &quot;RAPIOMICS-PLEX: A Platform for Rapid Detection of Highly-Multiplexed Multi-Omics Biomarker Panel.&quot; This firm fixed-price purchase order, awarded on October 9, 2024, is set aside for small businesses and carries an ultimate completion date of May 8, 2025. The contract will be performed in Huntsville, Alabama, leveraging CFD Research's...

This is a $240,000.00 firm fixed price contract awarded by the Department of the Army Materiel Command Research Development and Engineering Command to Intralytix Inc., a for-profit biotech organization that specializes in bacteriophage-based products for food safety and public health applications. The contract, which does not have a set-aside designation, is for the &quot;Elucidation of Interaction of Bacteriophages with Bacteria in Various Food Matrixes, and the Impact on the Food...

This firm fixed-price purchase order, awarded by the Defense Health Agency (DHA) to Medpharm (doing business as Procara), is for the supply and delivery of BioFire FILMARRAY 423742 medical equipment. The $249,719.20 contract, which has a total small business set-aside, supports the DHA's medical readiness efforts, particularly in the Pacific region. As a minority-owned small disadvantaged business, Procara has established itself as a key supplier of laboratory equipment, reagents, and associated...

<p>This is a $1,999,175.53 firm fixed-price Definitive Contract awarded by the Defense Health Agency (DHA), a defense agency, to Technovax Inc., a small disadvantaged business, under the SBIR (Small Business Innovation Research) Phase II program. The contract is for research and development work, with a period of performance ending on February 16, 2021. The contract was set aside for small businesses.</p>